Dose Escalation of HSP990 in Japan/Korea

Clinical trial NCT01064089 · TERMINATED

Trial details

NCT number: NCT01064089
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2010-02-01
Primary completion: 2012-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.